The fully linked HTML version of this article has now been published.
Development ePress online publication date 20 Apr 2005
doi: 10.1242/dev.01793
Research article: Development and disease
Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma
Trudy G. Oliver,
Tracy Ann Read,
Jessica D. Kessler,
Anriada Mehmeti,
Jonathan F. Wells,
Trang T.T. Huynh,
Simon M. Lin,
and
Robert J. Wechsler-Reya*
* Author for correspondence (e-mail: rw.reya{at}duke.edu)
Medulloblastoma is the most common malignant brain tumor in children. It is thought to result from the transformation of granule cell precursors (GCPs) in the developing cerebellum, but little is known about the early stages of the disease. Here, we identify a pre-neoplastic stage of medulloblastoma in patched heterozygous mice, a model of the human disease. We show that pre-neoplastic cells are present in the majority of patched mutants, although only 16% of these mice develop tumors. Pre-neoplastic cells, like tumor cells, exhibit activation of the Sonic hedgehog pathway and constitutive proliferation. Importantly, they also lack expression of the wild-type patched allele, suggesting that loss of patched is an early event in tumorigenesis. Although pre-neoplastic cells resemble GCPs and tumor cells in many respects, they have a distinct molecular signature. Genes that mark the pre-neoplastic stage include regulators of migration, apoptosis and differentiation, processes crucial for normal development but previously unrecognized for their role in medulloblastoma. The identification and molecular characterization of pre-neoplastic cells provides insight into the early steps in medulloblastoma formation, and may yield important markers for early detection and therapy of this disease.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. M. Rudin, C. L. Hann, J. Laterra, R. L. Yauch, C. A. Callahan, L. Fu, T. Holcomb, J. Stinson, S. E. Gould, B. Coleman, et al.
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
N. Engl. J. Med.,
September 17, 2009;
361(12):
1173 - 1178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Ward, L. Lee, K. Graham, T. Satkunendran, K. Yoshikawa, E. Ling, L. Harper, R. Austin, E. Nieuwenhuis, I. D. Clarke, et al.
Multipotent CD15+ Cancer Stem Cells in Patched-1-Deficient Mouse Medulloblastoma
Cancer Res.,
June 1, 2009;
69(11):
4682 - 4690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Uziel, F. V. Karginov, S. Xie, J. S. Parker, Y.-D. Wang, A. Gajjar, L. He, D. Ellison, R. J. Gilbertson, G. Hannon, et al.
The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma
PNAS,
February 24, 2009;
106(8):
2812 - 2817.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-O. Frappart, Y. Lee, H. R. Russell, N. Chalhoub, Y.-D. Wang, K. E. Orii, J. Zhao, N. Kondo, S. J. Baker, and P. J. McKinnon
Recurrent genomic alterations characterize medulloblastoma arising from DNA double-strand break repair deficiency
PNAS,
February 10, 2009;
106(6):
1880 - 1885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Kessler, H. Hasegawa, S. N. Brun, B. A. Emmenegger, Z.-J. Yang, J. W. Dutton, F. Wang, and R. J. Wechsler-Reya
N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma
Genes & Dev.,
January 15, 2009;
23(2):
157 - 170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Ayrault, F. Zindy, J. Rehg, C. J. Sherr, and M. F. Roussel
Two Tumor Suppressors, p27Kip1 and Patched-1, Collaborate to Prevent Medulloblastoma
Mol. Cancer Res.,
January 1, 2009;
7(1):
33 - 40.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Briggs, C. G. Eberhart, and D. N. Watkins
Just Say No to ATOH: How HIC1 Methylation Might Predispose Medulloblastoma to Lineage Addiction
Cancer Res.,
November 1, 2008;
68(21):
8654 - 8656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Corcoran, T. Bachar Raveh, M. T. Barakat, E. Y. Lee, and M. P. Scott
Insulin-like Growth Factor 2 Is Required for Progression to Advanced Medulloblastoma in patched1 Heterozygous Mice
Cancer Res.,
November 1, 2008;
68(21):
8788 - 8795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Emmenegger and R. J. Wechsler-Reya
Stem Cells and the Origin and Propagation of Brain Tumors
J Child Neurol,
October 1, 2008;
23(10):
1172 - 1178.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. MacDonald
Aggressive Infantile Embryonal Tumors
J Child Neurol,
October 1, 2008;
23(10):
1195 - 1204.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tanori, M. Mancuso, E. Pasquali, S. Leonardi, S. Rebessi, V. Di Majo, M.-N. Guilly, F. Giangaspero, V. Covelli, S. Pazzaglia, et al.
PARP-1 cooperates with Ptc1 to suppress medulloblastoma and basal cell carcinoma
Carcinogenesis,
October 1, 2008;
29(10):
1911 - 1919.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mancuso, E. Pasquali, S. Leonardi, M. Tanori, S. Rebessi, V. Di Majo, S. Pazzaglia, M. P. Toni, M. Pimpinella, V. Covelli, et al.
From the Cover: Oncogenic bystander radiation effects in Patched heterozygous mouse cerebellum
PNAS,
August 26, 2008;
105(34):
12445 - 12450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Fan and C. G. Eberhart
Medulloblastoma Stem Cells
J. Clin. Oncol.,
June 10, 2008;
26(17):
2821 - 2827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. B. Dirks
Brain Tumor Stem Cells: Bringing Order to the Chaos of Brain Cancer
J. Clin. Oncol.,
June 10, 2008;
26(17):
2916 - 2924.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Hatton, E. H. Villavicencio, K. D. Tsuchiya, J. I. Pritchard, S. Ditzler, B. Pullar, S. Hansen, S. E. Knoblaugh, D. Lee, C. G. Eberhart, et al.
The Smo/Smo Model: Hedgehog-Induced Medulloblastoma with 90% Incidence and Leptomeningeal Spread
Cancer Res.,
March 15, 2008;
68(6):
1768 - 1776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Briggs, I. M. Corcoran-Schwartz, W. Zhang, T. Harcke, W. L. Devereux, S. B. Baylin, C. G. Eberhart, and D. N. Watkins
Cooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma
Genes & Dev.,
March 15, 2008;
22(6):
770 - 785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. B Dirks
Brain tumour stem cells: the undercurrents of human brain cancer and their relationship to neural stem cells
Phil Trans R Soc B,
January 12, 2008;
363(1489):
139 - 152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Johnson, Y. Y. Huang, A. B. Parrish, M. I. Smith, A. E. Vaughn, Q. Zhang, K. M. Wright, T. Van Dyke, R. J. Wechsler-Reya, S. Kornbluth, et al.
Differential Apaf-1 levels allow cytochrome c to induce apoptosis in brain tumors but not in normal neural tissues
PNAS,
December 26, 2007;
104(52):
20820 - 20825.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Yun, J. M. Rust, T. Ishimaru, and E. Diaz
A Novel Role of the Mad Family Member Mad3 in Cerebellar Granule Neuron Precursor Proliferation
Mol. Cell. Biol.,
December 1, 2007;
27(23):
8178 - 8189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Farioli-Vecchioli, M. Tanori, L. Micheli, M. Mancuso, L. Leonardi, A. Saran, M. T. Ciotti, E. Ferretti, A. Gulino, S. Pazzaglia, et al.
Inhibition of medulloblastoma tumorigenesis by the antiproliferative and pro-differentiative gene PC3
FASEB J,
July 1, 2007;
21(9):
2215 - 2225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Sasai, J. T. Romer, H. Kimura, D. E. Eberhart, D. S. Rice, and T. Curran
Medulloblastomas Derived from Cxcr6 Mutant Mice Respond to Treatment with a Smoothened Inhibitor
Cancer Res.,
April 15, 2007;
67(8):
3871 - 3877.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Fogarty, B. A. Emmenegger, L. L. Grasfeder, T. G. Oliver, and R. J. Wechsler-Reya
Fibroblast growth factor blocks Sonic hedgehog signaling in neuronal precursors and tumor cells
PNAS,
February 20, 2007;
104(8):
2973 - 2978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yang, E. Jackson, B. M. Woerner, A. Perry, D. Piwnica-Worms, and J. B. Rubin
Blocking CXCR4-Mediated Cyclic AMP Suppression Inhibits Brain Tumor Growth In vivo
Cancer Res.,
January 15, 2007;
67(2):
651 - 658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Mao, K. L. Ligon, E. Y. Rakhlin, S. P. Thayer, R. T. Bronson, D. Rowitch, and A. P. McMahon
A novel somatic mouse model to survey tumorigenic potential applied to the hedgehog pathway.
Cancer Res.,
October 15, 2006;
66(20):
10171 - 10178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Pogoriler, K. Millen, M. Utset, and W. Du
Loss of cyclin D1 impairs cerebellar development and suppresses medulloblastoma formation
Development,
October 1, 2006;
133(19):
3929 - 3937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Iacovelli, A. Arcella, G. Battaglia, S. Pazzaglia, E. Aronica, P. Spinsanti, A. Caruso, E. De Smaele, A. Saran, A. Gulino, et al.
Pharmacological Activation of mGlu4 Metabotropic Glutamate Receptors Inhibits the Growth of Medulloblastomas.
J. Neurosci.,
August 9, 2006;
26(32):
8388 - 8397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Lee, H. L. Miller, H. R. Russell, K. Boyd, T. Curran, and P. J. McKinnon
Patched2 modulates tumorigenesis in patched1 heterozygous mice.
Cancer Res.,
July 15, 2006;
66(14):
6964 - 6971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Shakhova, C. Leung, E. van Montfort, A. Berns, and S. Marino
Lack of Rb and p53 Delays Cerebellar Development and Predisposes to Large Cell Anaplastic Medulloblastoma through Amplification of N-Myc and Ptch2.
Cancer Res.,
May 15, 2006;
66(10):
5190 - 5200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Browd, A. M. Kenney, O. N. Gottfried, J. W. Yoon, D. Walterhouse, C. A. Pedone, and D. W. Fults
N-myc Can Substitute for Insulin-Like Growth Factor Signaling in a Mouse Model of Sonic Hedgehog-Induced Medulloblastoma.
Cancer Res.,
March 1, 2006;
66(5):
2666 - 2672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Uziel, F. Zindy, S. Xie, Y. Lee, A. Forget, S. Magdaleno, J. E. Rehg, C. Calabrese, D. Solecki, C. G. Eberhart, et al.
The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation
Genes & Dev.,
November 15, 2005;
19(22):
2656 - 2667.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2005